SHOULD PRE-S CODED PEPTIDES BE USED IN HEPATITIS B VACCINES?
- 1 February 1986
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 327 (8477) , 389-390
- https://doi.org/10.1016/s0140-6736(86)92358-5
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Human Serum Albumin and the Enigma of Chronic Hepatitis Type BScandinavian Journal of Immunology, 1986
- RECEPTOR ACTIVITY FOR POLYMERISED HUMAN ALBUMIN IN HEPATITIS B VACCINEThe Lancet, 1985
- Enhanced Immunogenicity of the Pre-S Region of Hepatitis B Surface AntigenScience, 1985
- HEPATITIS B VACCINE WITH AND WITHOUT POLYMERISED ALBUMIN RECEPTORSThe Lancet, 1985
- Hepatitis B virus contains pre-S gene-encoded domainsNature, 1985
- Protection against hepatitis B virus infection by immunization with hepatitis B core antigenGastroenterology, 1985
- Occurrence of AUSAB Test Positivity Unrelated to Prior Exposure to Hepatitis B VirusThe Journal of Infectious Diseases, 1984
- HEPATITIS B VACCINATION: HOW LONG DOES PROTECTION LAST?The Lancet, 1984
- A Polypeptide Containing 55 Amino Acid Residues Coded by the Pre-S Region of Hepatitis B Virus Deoxyribonucleic Acid Bears the Receptor for Polymerized Human as Well as Chimpanzee AlbuminsGastroenterology, 1984
- Structural Relationships Between Minor and Major Proteins of Hepatitis B Surface AntigenJournal of Virology, 1983